Jiaming Su
Impact in
- Immunology top 10%
- interferon and immune responses
- Infectious Diseases top 10%
- Viral Infections and Vectors
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Epigenetics and DNA Methylation 5
- Genomics and Chromatin Dynamics 4
- Histone Deacetylase Inhibitors Research 3
- Inflammasome and immune disorders 3
- Ubiquitin and proteasome pathways 2
-
- Viral Infections and Vectors 8
- Co-authors
- Yong Cai (6 shared papers)Jingji Jin (6 shared papers)Yajuan Rui (13 shared papers)Fei Wang (3 shared papers)Wenwen Zheng (7 shared papers)Yong Cai (5 shared papers)Xiao‐Fang Yu (7 shared papers)Wei Wei (5 shared papers)
- Journals
- Journal of Medical Virology (4 papers)Signal Transduction and Targeted Therapy (3 papers)Journal of Virology (2 papers)Frontiers in Immunology (2 papers)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Jiaming Su
27 papers receiving 706 citations
Peers
Comparison fields: 5 of 69
- Immunology 256
- Infectious Diseases 205
- Virology 32
- Molecular Biology 394
- Cancer Research 61
Countries citing papers authored by Jiaming Su
This map shows the geographic impact of Jiaming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaming Su more than expected).
Fields of papers citing papers by Jiaming Su
This network shows the impact of papers produced by Jiaming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaming Su. The network helps show where Jiaming Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiaming Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 99 | |
| 2 | 2016 | 74 | |
| 3 | 2017 | 67 | |
| 4 | 2013 | 54 | |
| 5 | 2014 | 54 | |
| 6 | 2019 | 50 | |
| 7 | 2022 | 48 | |
| 8 | 2013 | 43 | |
| 9 | 2022 | 33 | |
| 10 | 2017 | 25 | |
| 11 | 2023 | 20 | |
| 12 | 2016 | 20 | |
| 13 | 2015 | 20 | |
| 14 | 2022 | 15 | |
| 15 | 2023 | 14 | |
| 16 | 2008 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2024 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2024 | 7 |
About Jiaming Su
Jiaming Su is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Cancer Research and Epidemiology, having authored 30 papers that have together received 714 indexed citations. Recurring topics across this work include interferon and immune responses (9 papers), Viral Infections and Vectors (8 papers), Epigenetics and DNA Methylation (5 papers), Genomics and Chromatin Dynamics (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Inflammasome and immune disorders (3 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Immunology (256 citations), Infectious Diseases (205 citations), Virology (32 citations), Molecular Biology (394 citations) and Cancer Research (61 citations). Jiaming Su has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Yong Cai, Jingji Jin, Yajuan Rui, Fei Wang, Wenwen Zheng, Yong Cai, Xiao‐Fang Yu, Wei Wei, Meng Lou and Lingling Cao. Their work appears in journals such as Journal of Medical Virology, Signal Transduction and Targeted Therapy, Journal of Virology, Frontiers in Immunology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.